Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The genomic and biological complexity of mixed phenotype acute leukemia.

Critical reviews in clinical laboratory sciences - 1 May 2021

Andrews Claire, Tierens Anne, Minden Mark

Abstract excerpt

Mixed phenotype acute leukemia (MPAL) is a heterogeneous group of leukemias that are defined immunophenotypically by antigen expression on blasts of both myeloid and lymphoid lineage. With the exception of BCR-ABL positive and KMT2A rearranged MPAL, the biology of the majority of MPAL remains uncertain. Several recent studies have explored the genomic and epigenetic landscape of MPAL and have suggested a further...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fusion Proteins, bcr-abl
Share to Genomics
Share to Phenotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Source

Identifiers

PMID: 33161794
DOI: 10.1080/10408363.2020.1829537

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The genomic and biological complexity of mixed phenotype acute leukemia.PMID 33161794Read ↗

Mixed-phenotype acute leukemia: current challenges in diagnosis and therapy.Semantic proximity Read ↗

Genomic Landscape of Mixed-Phenotype Acute Leukemia.Semantic proximity Read ↗

Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes.Semantic proximity Read ↗

Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia.Semantic proximity Read ↗

Mixed-Phenotype Acute Leukemia: Clinical Diagnosis and Therapeutic StrategiesSemantic proximity Read ↗

An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL).Semantic proximity Read ↗

Pediatric Mixed-Phenotype Acute Leukemia: What’s New?Semantic proximity Read ↗

Mixed Phenotype/Lineage Leukemia: Has Anything Changed for 2021 on Diagnosis, Classification, and Treatment?Semantic proximity Read ↗

Mixed-phenotype acute leukemia (MPAL) exhibits frequent mutations in DNMT3A and activated signaling genes.Semantic proximity Read ↗

Mixed-phenotype acute leukemia: state-of-the-art of the diagnosis, classification and treatment.Semantic proximity Read ↗

Multiomic single cell sequencing identifies stemlike nature of mixed phenotype acute leukemia.Semantic proximity Read ↗

Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.